Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Thymalfasin × Thoracic × Clear all
NCT06607926 2024-09-23

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Xuanwu Hospital, Beijing

Phase NA Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06598839 2024-09-19

Immuno-effect of Tα1 for Stage I NSCLC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡